Pelvic insufficiency fractures after chemoradiotherapy for cervical cancer: incidence, long-term outcomes, and survivorship management
The Oncologist · 05.11.2026 · 31 (12)
DOI: 10.1093/oncolo/oyag427 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 22.10.2026. Verfasst von Akram Saad und 14 weiteren Autor:innen. Beteiligte Einrichtung: Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Fractures, Stress, Pelvic Bones. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pelvic insufficiency fractures, a late complication of chemoradiotherapy for cervical cancer, can cause pain and functional impairment. Although most studies have reported incidence rates and risk factors, few have examined clinical presentation, long-term symptom burden, or the impact on survivorship.
Methods
We conducted a retrospective study of patients with cervical cancer treated with chemoradiotherapy from 2018 to 2024. We extracted clinical characteristics, treatment details, dosimetric parameters, imaging studies documenting pelvic insufficiency fractures, and clinical outcomes from the electronic medical record. We used the Kaplan–Meier method to estimate the probability of pelvic insufficiency fractures and univariate Cox regression to assess clinical and dosimetric factors associated with their development.
Results
The cohort comprised 153 patients (median follow-up: 41.4 months). After chemoradiotherapy, 18 patients (11.8%) developed radiologically confirmed pelvic insufficiency fractures (median time to diagnosis: 9.5 months; probability of pelvic insufficiency fracture at 24 months: 11.4%). PET-CT and/or MRI showed that most pelvic insufficiency fractures involved the sacrum. No statistically significant clinical or dosimetric predictors of pelvic insufficiency fractures were identified. All symptomatic patients (n = 15, 83%) required referral to pain management services (median observed duration of symptoms: 37 months). No symptomatic patient achieved documented complete symptom resolution during the available follow-up.
Conclusions
Most pelvic insufficiency fractures presented with new-onset pelvic or sacral pain within 2 years of completing chemoradiotherapy. The lack of clinical or dosimetric predictors suggests a multifactorial etiology of fracture risk. Persistent pain, despite multimodal supportive care, led to long-term morbidity. These findings underscore the need for prospective studies to develop evidence-based preventive strategies, survivorship assessments, and management pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
- Department of Medical Oncology, Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, 5265601, Israel.
- Department of Radiation Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel.
- Gynecologic Oncology Unit, Sheba Medical Center, Tel Hashomer, 5265601, Israel.
- Department of Radiation Oncology, Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, 5265601, Israel.
- Clinical Research Laboratory, Meir Medical Center, Kfar Saba, 4428164, Israel.
ORCID-Profile: Akram Saad, Ronza Atamneh, Limor Helpman, Ronnie Shapira, Omer Berner, Dana Oren, Alexandra Taylor, Shira Peleg Hasson
Zitieren
APA
Saad, A., Goldstein, J., Atamneh, R., Helpman, L., Shapira, R., Berner, O., Morag, O., Jacobi, O., Oren, D., Abu-Toamih Atamni, H. J., Mordechai, R., Aryeh, I. G., Taylor, A., Peleg Hasson, S., & Felder, S. (2026). Pelvic insufficiency fractures after chemoradiotherapy for cervical cancer: incidence, long-term outcomes, and survivorship management. The Oncologist, 31(12). https://doi.org/10.1093/oncolo/oyag427
Vancouver
Saad A, Goldstein J, Atamneh R, Helpman L, Shapira R, Berner O, et al. Pelvic insufficiency fractures after chemoradiotherapy for cervical cancer: incidence, long-term outcomes, and survivorship management. The Oncologist. 2026;31(12). doi:10.1093/oncolo/oyag427
BibTeX
@article{Saad2026,
author = {Saad, Akram and Goldstein, Jeffrey and Atamneh, Ronza and Helpman, Limor and Shapira, Ronnie and Berner, Omer and Morag, Ofir and Jacobi, Oded and Oren, Dana and Abu-Toamih Atamni, Hanifa J and Mordechai, Reut and Aryeh, Itay Goor and Taylor, Alexandra and Peleg Hasson, Shira and Felder, Shira},
title = {Pelvic insufficiency fractures after chemoradiotherapy for cervical cancer: incidence, long-term outcomes, and survivorship management},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {12},
doi = {10.1093/oncolo/oyag427}
}
EUVIMED